AI-DERIVED AUTOMATED QUANTIFICATION OF CARDIAC CHAMBERS AND MYOCARDIUM FROM NON-CONTRAST CT: PREDICTION OF ADVERSE CARDIOVASCULAR EVENTS IN ASYMPTOMATIC SUBJECTS

Therapeutic AreaASCVD/CVD Risk Assessment BackgroundThe significance of myocardial mass and chamber volumes from non-contrast computed tomography (CT) for predicting major adverse cardiovascular events (MACE) has not been studied. Our objective was to evaluate the role of artificial intelligence-ena...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of preventive cardiology Vol. 19; p. 100850
Main Author Razipour, Aryabod, MD
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2024
Elsevier
Subjects
Online AccessGet full text
ISSN2666-6677
2666-6677
DOI10.1016/j.ajpc.2024.100850

Cover

More Information
Summary:Therapeutic AreaASCVD/CVD Risk Assessment BackgroundThe significance of myocardial mass and chamber volumes from non-contrast computed tomography (CT) for predicting major adverse cardiovascular events (MACE) has not been studied. Our objective was to evaluate the role of artificial intelligence-enabled multi-chamber cardiac volumetry from non-contrast CT for long-term risk stratification in asymptomatic subjects without known coronary artery disease. MethodsOur study included 2022 asymptomatic individuals (55.6±9.0 years; 59.2% male) from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) trial. The multi-chamber cardiac volumetry was performed using deep-learning algorithms from routine non-contrast CT scans for coronary artery calcium scoring. MACE was defined as myocardial infarction, late (>180 days) revascularization, and cardiac death. ResultsA total of 215 individuals (11%) suffered MACE at a mean follow-up of 13.9±3 years. Individuals with MACE, as compared to those without MACE, had higher left ventricle (LV) myocardial mass (118.1 g vs 106.9 g, p<0.001) and higher LV chamber volume (105.0 cm3 vs. 96.9 cm3, p<0.001). In multivariable logistic regression, LV myocardial mass (HR 1.19[95% CI 1.04-1.36] per standard deviation) and left ventricular volume (HR 1.16 [95% CI 1.02-1.32] per standard deviation) were independent predictors of MACE. Patients with the highest LV myocardial mass (> 118.1 g) and chamber (> 105.0 cm3) volume, as divided into tertiles, presented a steep increase in the risk of MACE (log rank p<0.001). ConclusionsLV volume and myocardial mass quantified automatically by AI from routine non-contrast CT independently predicted long-term MACE risk in asymptomatic patients without known coronary artery disease. AI-derived LV measurements from routine non-contrast cardiac CT without physician interaction may improve the risk stratification of MACE.
ISSN:2666-6677
2666-6677
DOI:10.1016/j.ajpc.2024.100850